Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck EBITDA 2010-2024 | MKKGY

Merck annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Merck EBITDA for the quarter ending June 30, 2024 was $1.582B, a 0.55% decline year-over-year.
  • Merck EBITDA for the twelve months ending June 30, 2024 was $5.836B, a 9.58% decline year-over-year.
  • Merck 2023 annual EBITDA was $5.942B, a 13.29% decline from 2022.
  • Merck 2022 annual EBITDA was $6.853B, a 2.49% decline from 2021.
  • Merck 2021 annual EBITDA was $7.028B, a 24.97% increase from 2020.
  
Merck Annual EBITDA
(Millions of US $)
2023 $5,942
2022 $6,853
2021 $7,028
2020 $5,624
2019 $4,552
2018 $4,178
2017 $4,841
2016 $4,887
2015 $3,722
2014 $4,151
2013 $4,830
2012 $3,780
2011 $1,555
2010 $12,338
2009 $10,807
Merck Quarterly EBITDA
(Millions of US $)
2024-06-30 $1,582
2024-03-31 $1,504
2023-12-31 $1,208
2023-09-30 $1,543
2023-06-30 $1,591
2023-03-31 $1,600
2022-12-31 $1,601
2022-09-30 $1,662
2022-06-30 $1,791
2022-03-31 $1,799
2021-12-31 $1,753
2021-09-30 $1,738
2021-06-30 $1,768
2021-03-31 $1,769
2020-12-31 $1,244
2020-09-30 $1,958
2020-06-30 $1,156
2020-03-31 $1,265
2019-12-31 $1,202
2019-09-30 $1,183
2019-06-30 $1,199
2019-03-31 $968
2018-12-31 $985
2018-09-30 $1,042
2018-06-30 $987
2018-03-31 $1,164
2017-12-31 $822
2017-09-30 $1,613
2017-06-30 $1,124
2017-03-31 $1,282
2016-12-31 $1,027
2016-09-30 $1,226
2016-06-30 $1,220
2016-03-31 $1,414
2015-12-31 $886
2015-09-30 $1,023
2015-06-30 $926
2015-03-31 $941
2014-12-31 $620
2014-09-30 $1,009
2014-06-30 $952
2014-03-31 $1,057
2013-12-31 $1,155
2013-09-30 $1,259
2013-06-30 $1,292
2013-03-31 $1,111
2012-12-31 $3,646
2012-09-30 $601
2012-06-30 $79
2012-03-31 $3,274
2011-12-31 $3,311
2011-09-30 $3,585
2011-06-30 $151
2011-03-31 $3,505
2010-12-31 $3,707
2010-09-30 $618
2010-06-30 $2,695
2010-03-31 $2,791
2009-12-31 $2,983
2009-09-30 $2,778
2009-06-30 $2,590
2009-03-31 $2,456
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $19.192B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.770B 30.70
Takeda Pharmaceutical (TAK) Japan $44.101B 9.18
Astellas Pharma (ALPMY) Japan $19.074B 17.57
Sandoz Group AG (SDZNY) Switzerland $18.921B 0.00
United Therapeutics (UTHR) United States $16.524B 16.25
Summit Therapeutics (SMMT) United States $13.635B 0.00
Neurocrine Biosciences (NBIX) United States $12.746B 33.75
Shionogi (SGIOY) Japan $11.978B 12.00
Catalent (CTLT) United States $11.150B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.948B 0.00
Orion OYJ (ORINY) Finland $6.605B 18.57
Corcept Therapeutics (CORT) United States $6.204B 46.99
Ionis Pharmaceuticals (IONS) United States $5.700B 0.00
Crinetics Pharmaceuticals (CRNX) United States $5.322B 0.00
PTC Therapeutics (PTCT) United States $4.016B 0.00
Dyne Therapeutics (DYN) United States $2.980B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.687B 12.18
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.655B 15.87
Centessa Pharmaceuticals (CNTA) United Kingdom $2.235B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.173B 0.00
Soleno Therapeutics (SLNO) United States $2.156B 0.00
Xencor (XNCR) United States $1.878B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.814B 0.00
Evotec AG (EVO) Germany $1.673B 0.00
Indivior (INDV) United States $1.548B 6.31
Guardian Pharmacy Services (GRDN) United States $1.537B 0.00
Ocular Therapeutix (OCUL) United States $1.536B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.529B 0.00
Harrow (HROW) United States $1.491B 0.00
Ardelyx (ARDX) United States $1.312B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.303B 0.00
ARS Pharmaceuticals (SPRY) United States $1.295B 0.00
Enliven Therapeutics (ELVN) United States $1.194B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.117B 0.00
Collegium Pharmaceutical (COLL) United States $1.010B 5.52
Bioventus (BVS) United States $0.997B 31.49
Cronos Group (CRON) Canada $0.791B 0.00
Relay Therapeutics (RLAY) United States $0.782B 0.00
USANA Health Sciences (USNA) United States $0.763B 14.14
Oruka Therapeutics (ORKA) United States $0.734B 0.00
Tourmaline Bio (TRML) United States $0.658B 0.00
Elite Pharmaceuticals (ELTP) United States $0.646B 0.00
Altimmune (ALT) United States $0.629B 0.00
ProKidney (PROK) United States $0.621B 0.00
Esperion Therapeutics (ESPR) United States $0.611B 0.00
Verve Therapeutics (VERV) United States $0.606B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.579B 0.00
Savara (SVRA) United States $0.567B 0.00
OmniAb (OABI) United States $0.562B 0.00
Zevra Therapeutics (ZVRA) United States $0.517B 0.00
Organogenesis (ORGO) United States $0.512B 0.00
Siga Technologies (SIGA) United States $0.511B 5.96
Xeris Biopharma Holdings (XERS) United States $0.504B 0.00
Korro Bio (KRRO) United States $0.501B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.476B 193.21
Akebia Therapeutics (AKBA) United States $0.465B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.464B 0.00
KalVista Pharmaceuticals (KALV) United States $0.444B 0.00
Aquestive Therapeutics (AQST) United States $0.439B 0.00
Larimar Therapeutics (LRMR) United States $0.396B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.380B 0.00
Sage Therapeutics (SAGE) United States $0.354B 0.00
4D Molecular Therapeutics (FDMT) United States $0.351B 0.00
Avita Medical (RCEL) United States $0.341B 0.00
Nature's Sunshine Products (NATR) United States $0.310B 18.42
Lyell Immunopharma (LYEL) United States $0.292B 0.00
Aldeyra Therapeutics (ALDX) United States $0.287B 0.00
Aclaris Therapeutics (ACRS) United States $0.283B 0.00
Lexeo Therapeutics (LXEO) United States $0.278B 0.00
Silence Therapeutics (SLN) United Kingdom $0.245B 0.00
Acrivon Therapeutics (ACRV) United States $0.232B 0.00
Nektar Therapeutics (NKTR) United States $0.218B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.217B 0.00
Profound Medical (PROF) Canada $0.207B 0.00
MediWound (MDWD) Israel $0.195B 0.00
Heron Therapeutics (HRTX) United States $0.186B 0.00
Inhibikase Therapeutics (IKT) United States $0.185B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.182B 0.00
Galectin Therapeutics (GALT) United States $0.176B 0.00
Cassava Sciences (SAVA) United States $0.166B 0.00
Achieve Life Sciences (ACHV) Canada $0.151B 0.00
Nanobiotix S.A (NBTX) France $0.148B 0.00
Century Therapeutics (IPSC) United States $0.143B 0.00
CytoDyn (CYDY) United States $0.143B 0.00
VAXART, INC (VXRT) United States $0.135B 0.00
Cardiol Therapeutics (CRDL) Canada $0.128B 0.00
Telomir Pharmaceuticals (TELO) United States $0.126B 0.00
Fractyl Health (GUTS) United States $0.125B 0.00
Journey Medical (DERM) United States $0.122B 0.00
Pyxis Oncology (PYXS) United States $0.119B 0.00
Context Therapeutics (CNTX) United States $0.117B 0.00
Regulus Therapeutics (RGLS) United States $0.107B 0.00
Karyopharm Therapeutics (KPTI) United States $0.103B 0.00
Innate Pharma SA (IPHYF) France $0.103B 0.00
Avalo Therapeutics (AVTX) United States $0.102B 0.00
Inotiv (NOTV) United States $0.101B 0.00
Relmada Therapeutics (RLMD) United States $0.099B 0.00
Assertio Holdings (ASRT) United States $0.098B 25.62
Arch Biopartners (ACHFF) Canada $0.090B 0.00
PMV Pharmaceuticals (PMVP) United States $0.087B 0.00
Vivani Medical (VANI) United States $0.086B 0.00
OptiNose (OPTN) United States $0.081B 0.00
Metagenomi (MGX) United States $0.078B 0.00
ESSA Pharma (EPIX) Canada $0.078B 0.00
Swiftmerge Acquisition (IVCP) United States $0.077B 0.00
Unicycive Therapeutics (UNCY) United States $0.076B 0.00
ElectroCore (ECOR) United States $0.074B 0.00
Mural Oncology (MURA) Ireland $0.071B 0.00
Scienture Holdings (SCNX) United States $0.066B 0.00
Iterum Therapeutics (ITRM) Ireland $0.066B 0.00
AlloVir (ALVR) United States $0.061B 0.00
CASI Pharmaceuticals (CASI) China $0.061B 0.00
Champions Oncology (CSBR) United States $0.059B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.058B 0.00
Prelude Therapeutics (PRLD) United States $0.058B 0.00
BioVie (BIVI) United States $0.055B 0.00
Protara Therapeutics (TARA) United States $0.052B 0.00
Nutriband (NTRB) United States $0.051B 0.00
SCYNEXIS (SCYX) United States $0.050B 0.00
Gain Therapeutics (GANX) United States $0.046B 0.00
Rafael Holdings (RFL) United States $0.045B 0.00
VYNE Therapeutics (VYNE) United States $0.042B 0.00
FibroGen (FGEN) United States $0.042B 0.00
Tempest Therapeutics (TPST) United States $0.042B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.040B 0.00
Surrozen (SRZN) United States $0.037B 0.00
Carisma Therapeutics (CARM) United States $0.035B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.035B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.032B 0.00
Incannex Healthcare (IXHL) Australia $0.030B 0.00
Natural Alternatives (NAII) United States $0.029B 0.00
DURECT (DRRX) United States $0.029B 0.00
CERo Therapeutics Holdings (CERO) United States $0.027B 0.00
BioLineRx (BLRX) Israel $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.023B 0.00
Lipocine (LPCN) United States $0.023B 0.00
GlycoMimetics (GLYC) United States $0.021B 0.00
ProPhase Labs (PRPH) United States $0.019B 0.00
Cosmos Health (COSM) United States $0.019B 0.00
MEI Pharma (MEIP) United States $0.018B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.018B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.018B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
Mannatech (MTEX) United States $0.017B 0.00
NRx Pharmaceuticals (NRXP) United States $0.016B 0.00
Minerva Neurosciences (NERV) United States $0.016B 0.00
TherapeuticsMD (TXMD) United States $0.016B 0.00
PolyPid (PYPD) Israel $0.016B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
Lyra Therapeutics (LYRA) United States $0.014B 0.00
Nuvilex (PMCB) United States $0.013B 0.00
Talphera (TLPH) United States $0.013B 0.00
Jaguar Animal Health (JAGX) United States $0.012B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.012B 0.00
Conduit Pharmaceuticals (CDT) United States $0.011B 0.00
Dominari Holdings (DOMH) United States $0.011B 0.00
Redhill Biopharma (RDHL) Israel $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Indaptus Therapeutics (INDP) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Klotho Neurosciences (KLTO) United States $0.009B 0.00
Plus Therapeutics (PSTV) United States $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Viracta Therapeutics (VIRX) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
Aditxt (ADTX) United States $0.005B 0.00
TransCode Therapeutics (RNAZ) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.11
Heatwurx (PCSA) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Molecular Templates (MTEM) United States $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Oncternal Therapeutics (ONCT) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 3.12
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 39.31